HELIX BIOPHARMA (HBP:TSE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HELIX BIOPHARMA (HBP:TSE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: trustmanic who wrote (147)	3/23/1998 10:06:00 PM
From: Jim-he	Read Replies (1) of 193

According to Terry, HBP is doing fine, $2 M cash is enough for 2 years to take the co. to profitability, HPB has been negotiating a worldwide distribution deal for its DNA testing business and a venture capital deal (instead of share offering) to raise more cash which will be announced soon. I think it is good to see HBP trying to focus on its core business and also good for shareholders if no more new shares are issued at such ridiculous price. This hi-tech co. is generating $4 revenue per year and now has market cap about $4 M ONLY. It is extremely undervalued even at current biotech bear market. Any small positive news would move the share price to the far north. News on the way......

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next